UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 587

Sortiert nach

Decoding the activity of neuronal populations in macaque primary visual cortex

Nature neuroscience, 2011-02, Vol.14 (2), p.239-245

2011

Link zum Volltext

Verfügbarkeit prüfen

Current anti-myeloma therapies in renal manifestations of monoclonal light chain-associated Fanconi syndrome: a retrospective series of 49 patients

Leukemia, 2017-01, Vol.31 (1), p.123-129

2017

Link zum Volltext

Verfügbarkeit prüfen

Nucleotide excision repair is a potential therapeutic target in multiple myeloma

Leukemia, 2018-01, Vol.32 (1), p.111-119

2018

Link zum Volltext

Verfügbarkeit prüfen

Brain–machine interface for eye movements

Proceedings of the National Academy of Sciences - PNAS, 2014-12, Vol.111 (49), p.17630-17635

2014

Link zum Volltext

Verfügbarkeit prüfen

Rituximab with alkylating agent in anti‐myelin‐associated glycoprotein neuropathy: A retrospective study of 26 cases

British journal of haematology, 2024-06, Vol.204 (6), p.2484-2486

2024

Link zum Volltext

Verfügbarkeit prüfen

Perioral skin thickening revealing AL amyloidosis

Journal of the European Academy of Dermatology and Venereology, 2022-09, Vol.36 (9), p.e703-e705

2022

Link zum Volltext

Verfügbarkeit prüfen

Clinical presentation, therapeutic approach and outcome of primary cutaneous marginal zone B‐cell lymphoma presenting as AL amyloidoma of the skin

British journal of dermatology (1951), 2019-09, Vol.181 (3), p.607-609

2019

Link zum Volltext

Verfügbarkeit prüfen

Consolidation with VTd significantly improves the complete remission rate and time to progression following VTd induction and single autologous stem cell transplantation in multiple myeloma

Leukemia, 2013-11, Vol.27 (11), p.2242-2244

2013

Link zum Volltext

Verfügbarkeit prüfen

The human immunodeficiency virus-1 protease inhibitor nelfinavir impairs proteasome activity and inhibits the proliferation of multiple myeloma cells in vitro and in vivo

Haematologica (Roma), 2012-07, Vol.97 (7), p.1101-1109

2012

Link zum Volltext

Verfügbarkeit prüfen

Phenotypic and functional characterization of bone marrow mesenchymal stem cells derived from patients with multiple myeloma

Leukemia, 2007-01, Vol.21 (1), p.158-163

2007

Link zum Volltext

Verfügbarkeit prüfen

Coexisting cutaneous macroglobulinosis and scleredema of Buschke in a patient with a Waldenström Macroglobulinemia

Journal of the European Academy of Dermatology and Venereology, 2019-03, Vol.33 (3), p.e104-e106

2019

Link zum Volltext

Verfügbarkeit prüfen

KIR3DL2 expression in patients with adult T‐cell lymphoma/leukaemia

British journal of dermatology (1951), 2018-07, Vol.179 (1), p.197-199

2018

Link zum Volltext

Verfügbarkeit prüfen

Inferring eye position from populations of lateral intraparietal neurons

eLife, 2014-05, Vol.3, p.e02813-e02813

2014

Link zum Volltext

Verfügbarkeit prüfen

From neuronal populations to behavior: a computational journey

Frontiers in computational neuroscience, 2014-08, Vol.8, p.81-81

Graf, Arnulf B A

2014

Link zum Volltext

Verfügbarkeit prüfen

Safe and prolonged survival with long-term exposure to pomalidomide in relapsed/refractory myeloma

Annals of oncology, 2016-05, Vol.27 (5), p.902-907

2016

Link zum Volltext

Verfügbarkeit prüfen

ELRANATAMAB, A B-CELL MATURATION ANTIGEN-CD3 BISPECIFIC ANTIBODY, FOR PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: EXTENDED FOLLOW UP AND BIWEEKLY ADMINISTRATION FROM THE MAGNETISMM-3 STUDY

Hematology, Transfusion and Cell Therapy, 2023-10, Vol.45, p.S404-S405

2023

Link zum Volltext

Verfügbarkeit prüfen

EFFICACY AND SAFETY OF ELRANATAMAB IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA AND PRIOR B-CELL MATURATION ANTIGEN–DIRECTED THERAPIES: A POOLED ANALYSIS FROM MAGNETISMM STUDIES

Hematology, Transfusion and Cell Therapy, 2023-10, Vol.45, p.S405

2023

Link zum Volltext

Verfügbarkeit prüfen

P16 HEALTH‐RELATED QUALITY OF LIFE FOR FRAIL TRANSPLANT‐INELIGIBLE PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA TREATED WITH DARATUMUMAB, LENALIDOMIDE AND DEXAMETHASONE: SUBGROUP ANALYSIS OF MAIA TRIAL

HemaSphere, 2023-05, Vol.7 (S2), p.18-19

2023

Link zum Volltext

Verfügbarkeit prüfen

Prototype Classification: Insights from Machine Learning

Neural computation, 2009-01, Vol.21 (1), p.272-300

2009

Link zum Volltext

Verfügbarkeit prüfen

Non‐cirrhotic portal hypertension in necrobiotic xanthogranuloma associated with monoclonal gammopathy

Journal of the European Academy of Dermatology and Venereology, 2017-09, Vol.31 (9), p.e403-e405

2017

Link zum Volltext

Verfügbarkeit prüfen

A rare case of disseminated skin and mucosal necrobiotic xanthogranuloma and xanthoma

Journal of the European Academy of Dermatology and Venereology, 2017-01, Vol.31 (1), p.e3-e5

2017

Link zum Volltext

Verfügbarkeit prüfen

Catastrophic cryofibrinogenaemia associated with chronic lymphocytic leukaemia and salvage therapy using plasmapheresis and cyclophosphamide

Journal of the European Academy of Dermatology and Venereology, 2017-01, Vol.31 (1), p.e38-e39

2017

Link zum Volltext

Verfügbarkeit prüfen

P949: A PHASE 2 TRIAL OF ELRANATAMAB, A B‐CELL MATURATION ANTIGEN (BCMA)‐CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: INITIAL SAFETY RESULTS FOR MAGNETISMM‐3

HemaSphere, 2022-06, Vol.6 (Suppl), p.839-840

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 587

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(509)
Mit Volltextzugriff
(504)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of The American Ceramic Society
(13)
Leukemia
(13)
Blood
(12)
Annals Of Surgery
(11)
Neurology
(11)
Annales De Dermatologie Et De Vénéréologie
(9)
European Urology
(9)
Hemasphere
(9)
The Journal Of Urology
(9)
Annals Of Neurology
(8)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Decoding the activity of neuronal populations in macaque primary visual cortex

Current anti-myeloma therapies in renal manifestations of monoclonal light chain-associated Fanconi syndrome: a retrospective series of 49 patients

Nucleotide excision repair is a potential therapeutic target in multiple myeloma

Brain–machine interface for eye movements

Rituximab with alkylating agent in anti‐myelin‐associated glycoprotein neuropathy: A retrospective study of 26 cases

French early nationwide idecabtagene vicleucel chimeric antigen receptor T-cell therapy experience in patients with relapsed/refractory multiple myeloma (FENIX): A real-world IFM study from the DESCAR-T registry

Perioral skin thickening revealing AL amyloidosis

Clinical presentation, therapeutic approach and outcome of primary cutaneous marginal zone B‐cell lymphoma presenting as AL amyloidoma of the skin

Consolidation with VTd significantly improves the complete remission rate and time to progression following VTd induction and single autologous stem cell transplantation in multiple myeloma

The human immunodeficiency virus-1 protease inhibitor nelfinavir impairs proteasome activity and inhibits the proliferation of multiple myeloma cells in vitro and in vivo

Phenotypic and functional characterization of bone marrow mesenchymal stem cells derived from patients with multiple myeloma

Coexisting cutaneous macroglobulinosis and scleredema of Buschke in a patient with a Waldenström Macroglobulinemia

KIR3DL2 expression in patients with adult T‐cell lymphoma/leukaemia

Inferring eye position from populations of lateral intraparietal neurons

From neuronal populations to behavior: a computational journey

Safe and prolonged survival with long-term exposure to pomalidomide in relapsed/refractory myeloma

ELRANATAMAB, A B-CELL MATURATION ANTIGEN-CD3 BISPECIFIC ANTIBODY, FOR PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: EXTENDED FOLLOW UP AND BIWEEKLY ADMINISTRATION FROM THE MAGNETISMM-3 STUDY

EFFICACY AND SAFETY OF ELRANATAMAB IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA AND PRIOR B-CELL MATURATION ANTIGEN–DIRECTED THERAPIES: A POOLED ANALYSIS FROM MAGNETISMM STUDIES

B08 IDECABTAGENE VICLEUCEL VERSUS STANDARD REGIMENS IN PATIENTS WITH TRIPLE‐CLASS–EXPOSED RELAPSED AND REFRACTORY MULTIPLE MYELOMA: KARMMA‐3 A PHASE 3 RANDOMIZED CONTROLLED TRIAL

P16 HEALTH‐RELATED QUALITY OF LIFE FOR FRAIL TRANSPLANT‐INELIGIBLE PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA TREATED WITH DARATUMUMAB, LENALIDOMIDE AND DEXAMETHASONE: SUBGROUP ANALYSIS OF MAIA TRIAL

Prototype Classification: Insights from Machine Learning

Non‐cirrhotic portal hypertension in necrobiotic xanthogranuloma associated with monoclonal gammopathy

A rare case of disseminated skin and mucosal necrobiotic xanthogranuloma and xanthoma

Catastrophic cryofibrinogenaemia associated with chronic lymphocytic leukaemia and salvage therapy using plasmapheresis and cyclophosphamide

P949: A PHASE 2 TRIAL OF ELRANATAMAB, A B‐CELL MATURATION ANTIGEN (BCMA)‐CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: INITIAL SAFETY RESULTS FOR MAGNETISMM‐3

Suchergebnisse filtern